Showing 9,741 - 9,760 results of 42,192 for search '(( 50 ((ng decrease) OR (((we decrease) OR (a decrease)))) ) OR ( a point decrease ))', query time: 1.25s Refine Results
  1. 9741

    Final code and subtheme schematic. by Pallavi Oruganti (16024519)

    Published 2023
    “…These findings can contribute to a more detailed understanding of the role of human behavior and critical control points for zoonotic disease—a significant contributor to acute febrile illness in this rural, resource-limited setting.…”
  2. 9742

    S1 File - by Nicolas M. Philipp (13272198)

    Published 2023
    “…Various force-time metrics were extracted from the jump tasks, and linear mixed models with subject ID as the random factor, and time as the fixed factor were used to investigate changes across the three time points. To account for the performance during the repeat sprint protocol, a second, two factor model was performed with time and repeat sprint ability (RSA) as the fixed factors. …”
  3. 9743

    Primary research objectives. by Pallavi Oruganti (16024519)

    Published 2023
    “…These findings can contribute to a more detailed understanding of the role of human behavior and critical control points for zoonotic disease—a significant contributor to acute febrile illness in this rural, resource-limited setting.…”
  4. 9744
  5. 9745
  6. 9746
  7. 9747

    Final dataset. by Keiko Ochiai (21453423)

    Published 2025
    “…Additionally, we conducted a behavioral assessment of their cognitive functions related to interpersonal interactions, using an eye-tracking system to measure their gaze points at various social stimuli. …”
  8. 9748

    Demographic Characteristics of Participants. by Keiko Ochiai (21453423)

    Published 2025
    “…Additionally, we conducted a behavioral assessment of their cognitive functions related to interpersonal interactions, using an eye-tracking system to measure their gaze points at various social stimuli. …”
  9. 9749
  10. 9750
  11. 9751
  12. 9752
  13. 9753

    Shape-Based Reprofiling of FDA-Approved Drugs for the H<sub>1</sub> Histamine Receptor by Sridhar R. Vasudevan (589877)

    Published 2012
    “…Reprofiling of existing drugs to treat conditions not originally targeted is an attractive means of addressing the problem of a decreasing stream of approved drugs. To determine if 3D shape similarity can be used to rationalize an otherwise serendipitous process, we employed 3D shape-based virtual screening to reprofile existing FDA-approved drugs. …”
  14. 9754
  15. 9755
  16. 9756
  17. 9757
  18. 9758
  19. 9759
  20. 9760